PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1707393
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1707393
Global Pharmaceutical Analytical Testing Market is estimated to be valued at USD 9.16 Bn in 2025 and is expected to reach USD 16.65 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 9.16 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 8.90% | 2032 Value Projection: | USD 16.65 Bn |
Pharmaceutical analytical testing refers to the use of scientific techniques and methods to establish the identity, strength, quality, purity, and potency of drug products. It plays a crucial role in drug development and manufacturing processes to ensure patient safety. Analytical testing helps characterize drug substances, finished drug products, intermediates, ingredients in a drug product, and degradation products. It also aids in compound identification and quantification, purity analysis, dissolution or release testing, bioavailability or bioequivalence studies, and stability testing. The techniques used include chromatography, spectroscopy, titrimetry, and microscopy. With stringent regulatory norms and new drug approvals, the demand for quality control and analytical testing services from pharmaceutical and biotechnology companies is increasing significantly.
The global pharmaceutical analytical testing market is driven by factors such as rising drug research and development activities, tighter quality control norms, and increased outsourcing of testing needs by pharmaceutical companies. Moreover, advancements in analytical techniques such as HPLC, GC, NMR, and MS/MS are enabling superior characterization of complex drug molecules and their metabolites, thereby accelerating the market growth. However, high costs associated with analytical instruments and lack of skilled professionals are hindering the market to a certain extent. Growing generic and biosimilar drug markets in emerging nations offer lucrative opportunities for market players. In addition, increasing collaborations between analytical testing service providers and pharmaceutical firms will boost market revenues during the forecast period.
Detailed Segmentation-